Richard Daniell appointed as Managing Director of Teva UK Limited
Teva UK Limited has announced that Richard Daniell has been appointed as Managing Director, responsible for all Teva’s commercial activities in the UK.
List view / Grid view
Teva UK Limited has announced that Richard Daniell has been appointed as Managing Director, responsible for all Teva’s commercial activities in the UK.
1 November 2011 | By Abbott
FDA approval for the next-generation XIENCE PRIME™ Drug Eluting System...
31 October 2011 | By University of Strathclyde
A pioneering research institute to drive forward the search for new and better medicines to open...
28 October 2011 | By Pfizer
Pfizer Inc. has completed its acquisition of Icagen, Inc., through the merger of its wholly owned subsidiary, Eclipse Acquisition Corp., with and into Icagen...
28 October 2011 | By H. Lundbeck A/S
Lundbeck has appointed Jens Peter Balling and Iman Barilero as vice presidents in its research and development organisation...
27 October 2011 | By Mike Claybourn, Raman Product Manager, HORIBA Scientific, 16 rue du Canal, 91160 Longjumeau France
Raman spectroscopy, a technology that has a long pedigree of success in Pharmaceutical Development...
27 October 2011 | By Boehringer Ingelheim
Update across Europe on Pradaxa®...
26 October 2011 | By Biogen Idec
Positive top-line results announced...
26 October 2011 | By Bristol-Myers Squibb Company
Licensing agreement for Bristol-Myers Squibb to develop and commercialize a fixed-dose combination...
26 October 2011 | By GlaxoSmithKline
GSK has joined WIPO Re:Search...
26 October 2011 | By AstraZeneca
US FDA has extended the action date for dapagliflozin for the treatment of type 2 diabetes by three months...
25 October 2011 | By kdm communications
Tecan’s PMP™ option for Freedom EVO® workstations provides Swiss BioQuant with real-time quality control...
24 October 2011 | By H. Lundbeck A/S
The FDA has approved Onfi™ (clobazam)...
24 October 2011 | By Gilead Sciences Inc
Gilead & GlobeImmune enter into an exclusive worldwide license & collaboration agreement...
24 October 2011 | By Abbott
New test based on FISH technology detects chromosomal abnormality to help predict prognosis of patients with AML...